Synbiotics as a Microbiome-Based Strategy in Colorectal Cancer
Nutrients · 2026
DOI: 10.3390/nu18101591 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, 2026. Verfasst von Lucia Maria Procopciuc und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biochemistry, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Synbiotics, Gastrointestinal Microbiome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 190 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Colorectal cancer (CRC) is a multifactorial disease arising from dynamic interactions between gut microbiota, inflammatory processes, metabolic reprogramming, and dysregulated host signaling pathways. Increasing evidence highlights the potential of synbiotics—combinations of probiotics and prebiotics—as promising modulators of these processes. This review explores the mechanisms by which synbiotics influence CRC development and progression, integrating data from preclinical and clinical studies. Synbiotics exert beneficial effects by restoring microbial balance, enhancing the production of short-chain fatty acids (SCFAs), strengthening intestinal barrier integrity, and reducing chronic inflammation and oxidative stress. These functional changes converge on key molecular pathways, including Wnt/β-catenin, NF-κB, and PI3K/Akt/mTOR, which regulate tumor cell proliferation, survival, and immune responses. Preclinical studies consistently demonstrate anti-tumor effects, including reduced tumor growth, increased apoptosis, and modulation of the tumor microenvironment. Clinical evidence suggests that synbiotics may improve postoperative outcomes, reduce chemotherapy-related toxicity, and positively influence microbiome composition, although results remain heterogeneous. Emerging approaches focusing on microbiome profiling and personalized synbiotic interventions offer new opportunities for precision medicine in CRC. Overall, synbiotics represent a promising adjunctive strategy in colorectal cancer management, with potential to enhance therapeutic efficacy and improve patient outcomes. Further large-scale clinical studies are needed to validate their long-term benefits and establish standardized treatment protocols.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biochemistry, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.
- Department of Inorganic Chemistry, Faculty of Pharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
- Department of Pharmaceutical Biochemistry and Clinical Laboratory, Faculty of Pharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.
ORCID-Profile: Lucia Maria Procopciuc, Adrina Corina Hangan, Roxana Liana Lucaciu
Zitieren
APA
Procopciuc, L. M., Hangan, A. C., & Lucaciu, R. L. (2026). Synbiotics as a Microbiome-Based Strategy in Colorectal Cancer. Nutrients. https://doi.org/10.3390/nu18101591
Vancouver
Procopciuc LM, Hangan AC, Lucaciu RL. Synbiotics as a Microbiome-Based Strategy in Colorectal Cancer. Nutrients. 2026. doi:10.3390/nu18101591
BibTeX
@article{Procopciuc2026,
author = {Procopciuc, Lucia Maria and Hangan, Adrina Corina and Lucaciu, Roxana Liana},
title = {Synbiotics as a Microbiome-Based Strategy in Colorectal Cancer},
journal = {Nutrients},
year = {2026},
doi = {10.3390/nu18101591}
}
EUVIMED